ArticleBMC pulmonary medicine2026
Association between lipid accumulation product and asthma in US adults: evidence from the NHANES 2005-2020.
Article in BMC pulmonary medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundObesity has been recognized as a risk factor for both the onset and progression of asthma. The lipid accumulation product (LAP) is considered a reliable surrogate marker for visceral adiposity and its related metabolic complications. This study aimed to investigate the potential association between LAP and asthma in adults.
methodsData were obtained from the National Health and Nutrition Examination Survey (NHANES) spanning 2005 to March 2020. Multivariable logistic regression, smooth curve fitting, threshold effect analysis and subgroup analyses were conducted to evaluate the association between LAP and asthma in adults. In addition, sensitivity analyses were performed to assess the stability.
resultsWithin the sample of 16,861 participants, 1,432 (8.5%) were diagnosed with current asthma. After full adjustment, each one-unit increase in ln LAP was associated with 39% higher odds of asthma prevalence. Compared with those in the lowest quartile (Q1), participants in the highest quartile (Q4) of ln LAP had a 65% increase in the odds of asthma (OR = 1.65, 95% CI: 1.15-2.38). In addition, gender difference and diabetes status altered the association between LAP and asthma (P for interaction < 0.05).
conclusionsThis study highlights a significant association between LAP and asthma prevalence in adults, particularly among females and individuals with diabetes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.